Vivodyne

Private

Philadelphia, PennsylvaniaHealthcare & Life Scienceshttps://www.vivodyne.com/

Last Round

Series A

May 29, 2025

Total Funding Raised

$82M

Company Overview

Vivodyne is a biotechnology company that develops a microfluidic bioengineering platform for advancing single-cell 4D phenomics and facilitating drug discovery and cellular therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

organoiddrug discoveryanimal testing alternativelab-grown human tissuepreclinical testingorgan-on-a-chipbiotech platformclinical trial failurepredictive biologyhigh-throughput screeningin vitro testingAI-driven drug discoveryhuman-centric testingphenomicsdrug development services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vivodyne Comps

Public and private peers based on sector, stage, and business model.

Vivodyne comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Vivodyne Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	May 29, 2025
Seed	Nov 22, 2023
Seed	Mar 30, 2021

View all Funding Rounds

Key People

Founding team and executive leadership

Andrei Georgescu

Chief Executive Officer

Executive Team

Julie O'Shaughnessy

Chief Operating Officer And Board Director

Executive Team

Vivodyne Investors

Notable investors and investment history

Vivodyne investors
Investor	Rounds
Lingotto	Series A
Khosla Ventures	Series A, Seed
Kairos Ventures	Series A, Seed
Helena Capital	Series A
Helena Special Investments	Series A
Fortius Ventures	Series A
CS Ventures	Series A, Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

May 29, 2025
$40M round completed.
Feb 20, 2025
Partnered with a majority of top 10 multinational pharmaceutical companies.

View all signals

Vivodyne Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Vivodyne Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Vivodyne's valuation, stock price, and market status.

Firmographic Details

HeadquartersPhiladelphia, Pennsylvania

Employee Range40

Year Founded2020

Last FundingMay 29, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.